Does NEVIRAPINE Cause Lipodystrophy acquired? 288 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 288 reports of Lipodystrophy acquired have been filed in association with NEVIRAPINE (Nevirapine). This represents 4.3% of all adverse event reports for NEVIRAPINE.
288
Reports of Lipodystrophy acquired with NEVIRAPINE
4.3%
of all NEVIRAPINE reports
1
Deaths
39
Hospitalizations
How Dangerous Is Lipodystrophy acquired From NEVIRAPINE?
Of the 288 reports, 1 (0.3%) resulted in death, 39 (13.5%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Lipodystrophy acquired Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEVIRAPINE. However, 288 reports have been filed with the FAERS database.
What Other Side Effects Does NEVIRAPINE Cause?
Foetal exposure during pregnancy (1,337)
Drug resistance (862)
Virologic failure (813)
Viral mutation identified (518)
Death (514)
Exposure during pregnancy (462)
Pathogen resistance (356)
Treatment failure (340)
Maternal exposure during pregnancy (283)
Premature baby (251)
What Other Drugs Cause Lipodystrophy acquired?
LAMIVUDINE (383)
ZIDOVUDINE (313)
STAVUDINE (283)
RITONAVIR (254)
LOPINAVIR\RITONAVIR (230)
DIDANOSINE (216)
TENOFOVIR DISOPROXIL (205)
EFAVIRENZ (203)
INDINAVIR (195)
ABACAVIR (194)
Which NEVIRAPINE Alternatives Have Lower Lipodystrophy acquired Risk?
NEVIRAPINE vs NEXAVAR
NEVIRAPINE vs NEXIUM
NEVIRAPINE vs NEXPLANON
NEVIRAPINE vs NIACIN
NEVIRAPINE vs NIACINAMIDE